Waters Corporation is the world's leading specialty measurement company focused on improving human health and well-being through the application of high-value analytical technologies and industry leading scientific expertise. Accurate information is key for making important decisions for everyone from everyday consumers to scientists in the laboratory. Waters makes it possible for scientists to get the accurate information they need in a variety of areas. The company has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years.
"Waters remains focused on separation sciences and the market segments that we serve," says Davnet Donnelly, General Manager for the Western Region. "We strive to deliver benefit through sustained innovation and continuing to push the boundaries of our technology to enable our customers' success. We are one of the very few companies that can offer a complete, end-to-end solution with best-in-class technology and we pride ourselves on delivering quality, reliable and fit-for-purpose products to our customers."
The many Hacienda, Pleasanton, and Tri-Valley companies involved in biotechnology may be especially interested in the Waters BioAccord System, which was introduced in the beginning of 2019. The integrated system simplifies high performance liquid chromatography-mass spectrometry (LC-MS) analysis for every user. This easy-to-use system puts the power to make decisions directly in the hands of the user. It is a self-calibrating, self-optimizing, self-sufficient tool that enables scientists to consistently generate the kind of high-quality data needed to tackle the challenges of biopharmaceutical development. It promises to move routine monitoring out of centralized mass spectrometry labs and into the hands of more scientists by enabling more effective analysis of biotherapeutic protein attributes across development and within quality control organizations.
Waters has played an important role in the history of mass spectrometry, including in the development of some aspects of newborn screening. The expansion of newborn screening to include a unified panel of 34 inherited disorders was so successful in the United States that the Centers for Disease Control and Prevention have called it one of the 10 greatest public health achievements of the first decade of the 21st century. This expansion of newborn screening could only be achieved using mass spectrometry technology because the technique provides a relatively simple, rapid, and inexpensive way to screen for such a large panel of inborn metabolic disorders in a single analysis. The employees at Waters have made its history of innovation possible.
"Waters has over seven thousand employees worldwide and over half of them are in direct, customer-facing and supporting roles," says Hugh Holmes, District Sales Manager for the San Francisco District. "We also have an average employee tenure of over ten years with our company, which is virtually unheard of these days."
Waters moved to Hacienda in the fall of 2008. "The Hacienda location was ideal with an existing training facility and the opportunity to design custom lab spaces for our needs made this the perfect location," notes Holmes. "Being at the 580/680 junction makes Pleasanton a good location for customers from all over Northern California to get to us."
Waters is headquartered in Milford, Massachusetts. The Hacienda office functions as the largest regional office in the West Region, which encompasses 13 Western states. The Hacienda office also encompasses Waters' largest mass spectrometry demonstration facility in the United States outside of its Massachusetts headquarters. As a regional office, the Hacienda group of 12 employees support roughly 100 field employees who are based on the West Coast. Waters operates directly in 31 countries, including 15 manufacturing facilities. The company's products are available in more than 100 countries.
For more information about Waters Corporation, please visit www.waters.com.